Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA-874 (miR-874) is a small, non-coding RNA molecule located on chromosome 5q31.2 that functions primarily as a tumor suppressor by regulating the post-transcriptional silencing of multiple target genes across diverse biological pathways[4][7]. miR-874 is downregulated in numerous cancers and other diseases, and its decreased expression is linked to enhanced cell proliferation, reduced apoptosis, metastasis, and chemotherapy resistance. miR-874 acts through direct targeting of genes such as XIAP, PMVK, PPP1CA, and through involvement in ceRNA networks. It plays a central role in modulating major signaling pathways (e.g., Wnt/β-catenin, PI3K/AKT, Hippo), and its restoration suppresses tumor growth and enhances chemosensitivity in model systems[2][4][7]. Due to its downregulation and tumor suppressor function, miR-874 is considered both a biomarker and a potential therapeutic target in cancer diagnosis, prognosis, and treatment resistance.
Post-transcriptional gene silencing by binding to target mRNAs (e.g., XIAP, PMVK, PPP1CA, PAAF1, TGOLN2) to inhibit their expression; Regulation of competing endogenous RNA (ceRNA) networks involving other non-coding RNAs[2][4][5][7]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA-874 (miR-874).